Accessibility Menu
Novanta logo

Novanta(NASDAQ) NOVT

Market Cap$5.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1999)+792%
5 Year-6%
1 Year+20%
1 Month+3%
Premium Feature
Moneyball Superscore
67/100
$142.06
-1.79%
-2.60Today
After hours$142.32+$0.27 (+0.19%)
Novanta last closing stock price
MetricPriceDate
Last closeUSD 142.202026-08-28
Novanta stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.09%USD 145.242026-08-21
1 month+3.22%USD 137.772026-07-29
3 month-10.75%USD 159.332026-05-29
Year to date+19.51%USD 118.992025-12-31
1 year+20.44%USD 118.072025-08-28
3 year-11.17%USD 160.082023-08-29
5 year-5.86%USD 151.052021-08-27
Since inception+792.23%USD 15.941999-03-24

Novanta Financials at a Glance

Market Cap

$5.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$1.03B

Net Income (TTM)

$61.76M

EPS (TTM)

$1.56

P/E Ratio

90.89

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$142.06

Volume

265,466.06

Open

$145.78

Previous Close

$142.20

Daily Range

$140.97 - $146.31

52-Week Range

$98.27 - $176.38

Estimated Earnings Date

Nov 2, 2026

About Novanta

Novanta Inc. makes precision parts for medical and industrial tools. These parts help doctors perform surgeries and robots build products. The company assists manufacturers in creating highly accurate machines.

Tools for Precise Work

  • Medical Solutions: Designs and markets medical grade technologies like pumps and RFID solutions; serves the medical market which accounted for 52% of revenue for the six-month period ended July 3, 2026.
  • Automation Enabling Technologies: Manufactures laser scanning, robotic motion, and precision tooling; serves the advanced industrial market which accounted for 48% of revenue for the six-month period ended July 3, 2026.

Strategic Deals and Funding

  • Completed the acquisition of surgical consumable leader Riverpoint Medical for $1.2 billion in July 2026.
  • Closed a $300 million private placement of common shares in June 2026 with institutional investors.
  • Established $200 million in delayed draw term loan commitments through a credit agreement amendment in May 2026.
  • Acquired a company in 2025 that added $9 million to revenue during the six-month period ended July 3, 2026.

What Sets Novanta Apart

Novanta focuses on providing proprietary technology for long life-cycle platforms used by original equipment manufacturers. The company utilizes lean manufacturing principles and regional centers of excellence to improve operational efficiency.

Recent Performance Data

  • Total revenue reached $265.8 million for the three-month period ended July 3, 2026, up 10.3% year over year.
  • Operating income was $18.1 million for the three-month period ended July 3, 2026, up 21.1% year over year.
  • Basic earnings per share was $0.31 for the three-month period ended July 3, 2026, up $0.19 year over year.
  • Net cash provided by operating activities was $116.5 million for the six-month period ended July 3, 2026, up from $46.8 million in the prior year period.

Steady Evolution

Novanta has transitioned from its origins as GSI Group to a specialized provider of advanced photonics and precision motion solutions. Its focus on highly engineered components for medical and industrial applications supports its integration into critical supply chains.

AI Generated • Aug 6, 2026

Industry

Electronic Equipment, Instruments and Components

Employees

3,000

CEO

Matthijs Glastra, MBA

Headquarters

Bedford, MA 01730, US

NOVT Financials

Key Financial Metrics (TTM)

Gross Margin

42.52%

Operating Margin

10.43%

Net Income Margin

6.00%

Return on Equity

4.90%

Return on Capital

7.05%

Return on Assets

2.89%

Earnings Yield

1.10%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

37.82M

Volume

265.47K

Avg. Volume

500.52K

Financials (TTM)

Gross Profit

$437.85M

Operating Income

$107.42M

EBITDA

$139.60M

Operating Cash Flow

$133.84M

Capital Expenditure

-$19.56M

Free Cash Flow

$114.28M

Cash & ST Invst.

$718.65M

Total Debt

$282.82M

Novanta Performance Analysis

Novanta annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 860,903,00021.8%
20232023-12-31USD 881,662,0002.4%
20242024-12-31USD 949,245,0007.7%
20252025-12-31USD 980,600,0003.3%
Novanta sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-262.8%
Q42025-12-314.2%
Q12026-04-03-0.2%
Q22026-07-033.1%
Novanta annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 2.0646.6%
20232023-12-31USD 2.02-1.9%
20242024-12-31USD 1.77-12.3%
20252025-12-31USD 1.47-17.3%
Novanta sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-26150.0%
Q42025-12-3150.0%
Q12026-04-0313.3%
Q22026-07-03-41.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$265.81M

+10.3%

Gross Profit

$120.92M

+21.1%

Gross Margin

45.49%

N/A

Market Cap

$5.38BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.79M

N/A

Employees

3,000

N/A

Net Income

$12.54M

+178.9%

EBITDA

$17.00M

-37.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$718.65M

+553.8%

Total Debt

$282.82M

-44.9%

Accounts Receivable

$178.75M

+10.9%

Inventory

$192.71M

+14.7%

Long Term Debt

$231.44M

-53.5%

Short Term Debt

$51.38M

+231.3%

Return on Assets

2.89%

N/A

Return on Invested Capital

5.67%

N/A

Free Cash Flow

$58.76M

+402.9%

Operating Cash Flow

$66.23M

+339.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BULLWebull Corporation Class A Ordinary Shares
$9.37-2.09%
STSensata Technologies Holding plc
$41.03-3.44%
VNTVontier Corporation
$32.76-1.09%
BDCBelden Inc.
$115.21-3.95%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$217.55-0.05%
PCGPG&E
$16.60-0.08%
BITOProShares Trust - ProShares Bitcoin ETF
$10.45-0.03%
IRENIren
$35.45-0.13%

Questions About NOVT

What is the current price of Novanta?

Novanta is trading at $142.20 per share.

What is the 52-week range for Novanta?

Over the past 52 weeks, Novanta has traded between $98.27 and $176.38.

How much debt does Novanta have?

As of the most recent reporting period, Novanta reported total debt of $285.60M.

How much cash does Novanta have on hand?

Novanta reported $718.65M in cash and cash equivalents in its most recent financial results.

What is Novanta’s dividend yield?

Novanta does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.